CHA sent a comment letter to the FDA on draft guidance that recommends how and when manufacturers provide additional information in drug shortage notifications to the agency. Our letter urges the FDA to address the specific challenges facing the pediatric drug supply chain through transparency requirements, developing proactive shortage mitigation plans, and ensuring an accounting of pediatric drugs on the FDA drug shortages list.
CHA Submits Comments on FDA Drug Shortage Guidance
Children’s Hospital Association sends a comment letter to the FDA on draft drug shortage guidance to highlight the need for an efficient pediatric supply chain.
Related Content
CHA Submits House LHHS Appropriations Testimony
Joint Statement on Workplace Violence in Health Care
Supporting Safer Conversations in Pediatric Care
CHA Submits House LHHS Appropriations Testimony
CHA submitted witness testimony to the House LHHS Appropriations Subcommittee detailing FY27 requests on workforce, mental health, preparedness, research, and safety.
April 20, 2026
Joint Statement on Workplace Violence in Health Care
In health care settings, workplace violence affects nurses, physicians, technicians, pharmacists, support staff, patients, and families alike.
April 16, 2026
Supporting Safer Conversations in Pediatric Care
A new resource hub helps clinicians discuss firearm risks with patients and families in adaptable and evidence-informed ways.
April 13, 2026
